These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24794593)

  • 21. New Reports May Help Resolve the Conflict on Cholesterol Treatment Guidelines.
    Wallis L
    Am J Nurs; 2015 Oct; 115(10):16. PubMed ID: 26402274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia.
    Tshongo Muhindo C; Ahn SA; Rousseau MF; Dierckxsens Y; Hermans MP
    Complement Ther Med; 2017 Dec; 35():140-144. PubMed ID: 29154060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of statin characteristics on their safety and tolerability.
    De Angelis G
    Int J Clin Pract; 2004 Oct; 58(10):945-55. PubMed ID: 15587774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
    Nissen SE; Stroes E; Dent-Acosta RE; Rosenson RS; Lehman SJ; Sattar N; Preiss D; Bruckert E; Ceška R; Lepor N; Ballantyne CM; Gouni-Berthold I; Elliott M; Brennan DM; Wasserman SM; Somaratne R; Scott R; Stein EA;
    JAMA; 2016 Apr; 315(15):1580-90. PubMed ID: 27039291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 26. [New approaches in LDL cholesterol reduction].
    Füeßl HS
    MMW Fortschr Med; 2015 Jul; 157(13):39. PubMed ID: 26206031
    [No Abstract]   [Full Text] [Related]  

  • 27. Growing body of evidence shows benefits of aggressive lipid management in high-risk patients.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():3, 5. PubMed ID: 12608151
    [No Abstract]   [Full Text] [Related]  

  • 28. The safety of statins in children.
    Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V
    Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Don't trust an LDL over 70?
    Aronow WS
    Geriatrics; 2004 May; 59(5):12-3. PubMed ID: 15152729
    [No Abstract]   [Full Text] [Related]  

  • 30. Lowering LDL cholesterol is good, but how and in whom?
    Stone NJ; Lloyd-Jones DM
    N Engl J Med; 2015 Apr; 372(16):1564-5. PubMed ID: 25773740
    [No Abstract]   [Full Text] [Related]  

  • 31. PCSK9 Inhibitors and Cardiovascular Events.
    Sabatine MS; Wasserman SM; Stein EA
    N Engl J Med; 2015 Aug; 373(8):774-5. PubMed ID: 26295078
    [No Abstract]   [Full Text] [Related]  

  • 32. PCSK9 Inhibitors and Cardiovascular Events.
    Goemann IM; Londero TM; Dora JM
    N Engl J Med; 2015 Aug; 373(8):773-4. PubMed ID: 26287856
    [No Abstract]   [Full Text] [Related]  

  • 33. [Transplant coronary artery disease--treatment with statins].
    Wolszakiewicz J; Bilińska M
    Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Other reports of cerivastatin-induced rhabdomyolysis.
    Gabay M; Lodolce A
    Arch Intern Med; 2001 Nov; 161(21):2629. PubMed ID: 11718614
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid parameters and cardiovascular events in patients taking statins.
    Martin SS; Jones SR
    JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipid parameters and cardiovascular events in patients taking statins.
    Brook RD; Rubenfire M
    JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403
    [No Abstract]   [Full Text] [Related]  

  • 38. Case reports of rhabdomyolysis associated with cerivastatin therapy.
    Simpson S
    Arch Intern Med; 2001 Nov; 161(21):2630-1. PubMed ID: 11718617
    [No Abstract]   [Full Text] [Related]  

  • 39. PCSK9 inhibitors reduce cardiovascular events, preliminary data show.
    Mayor S
    BMJ; 2015 Mar; 350():h1508. PubMed ID: 25782694
    [No Abstract]   [Full Text] [Related]  

  • 40. Is intensive LDL-cholesterol lowering beneficial and safe?
    Cheung BM; Lam KS
    Lancet; 2010 Nov; 376(9753):1622-4. PubMed ID: 21067806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.